Tuberculosis: from genome to vaccine (Q36238724)

13 August 2017

1 reference

title

Tuberculosis: from genome to vaccine (English)

1 reference

13 August 2017

1 reference

Priscille Brodin

3

0 references

Roland Brosch

object named as

Roland Brosch

series ordinal

2

0 references

Caroline Demangel

series ordinal

4

object named as

Caroline Demangel

1 reference

13 August 2017

1

Marien I de Jonge

1 reference

13 August 2017

5

Stewart T Cole

1 reference

PubMed ID

16117711

13 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Expert Review of Vaccines

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

4

1 reference

13 August 2017

541-551

1 reference

Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA.

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

The TB epidemic from 1992 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

The diagnosis and therapy of tuberculosis during the past 100 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

The tuberculosis vaccine challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv with clinical isolate CDC 1551.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Regulation of the Mycobacterium tuberculosis PE/PPE genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Phospholipases C are involved in the virulence of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Stable association between strains of Mycobacterium tuberculosis and their human host populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Massive gene decay in the leprosy bacillus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Mycobacterial genome structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Comparative genomics of the leprosy and tubercle bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

A macrophage invasion mechanism of pathogenic mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Under-explored experimental topics related to integral mycobacterial vaccines for leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

The complete genome sequence of Mycobacterium bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

From genome to vaccine: in silico predictions, ex vivo verification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Developing an epitope-driven tuberculosis (TB) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Identification by mass spectrometry of CD8(+)-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

The Mycobacterium tuberculosis complex transcriptome of attenuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Immunology of tuberculosis and implications in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

An antimicrobial activity of cytolytic T cells mediated by granulysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Non-human primates: a model for tuberculosis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

New vaccines against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Developing an improved vaccine against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Current progress in tuberculosis vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

A new evolutionary scenario for the Mycobacterium tuberculosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Comprehensive identification of conditionally essential genes in mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Genetic requirements for mycobacterial survival during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

An essential role for phoP in Mycobacterium tuberculosis virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

An essential two-component signal transduction system in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Human immunity to M. tuberculosis: T cell subsets and antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Cell biology of mycobacterium tuberculosis phagosome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.541

21 January 2018

Identifiers

DOI

10.1586/14760584.4.4.541

1 reference

13 August 2017

1 reference

PubMed ID

16117711